Cell and Gene Therapy Market Soars with a 33.82% CAGR, Envisioned as a Billion-Dollar Landscape by 2027: BIS Research

Cell and gene therapy represent intersecting fields within biomedical research, sharing common therapeutic objectives that involve the manipulation of DNA or RNA either inside or outside the body. Both therapies are designed to alter genetic material to treat diseases. In gene therapy, genetic material or DNA is employed to modify a patient's cells, addressing inherited or acquired illnesses. On the other hand, cell therapy involves introducing new cells into a patient's body to foster the growth, replacement, or repair of damaged tissue for disease treatment. These therapies are broadly classified into therapeutic classes such as rare diseases, oncology, hematology, cardiovascular conditions, ophthalmology, neurology, and others. 

The global cell and gene therapy market was valued at $2.59 billion in 2020, and it is expected to grow at an impressive double-digit rate of 33.82% and reach a value of $25 billion in 2027. 

Several factors contribute to the current positive outlook of the cell and gene therapy market. These include the growing prevalence of cancer and other chronic diseases, rising clinical trials, increased funding and investments in the cell and gene therapy sector, and a favorable regulatory environment with FDA approvals for products in this domain. 

Market Analysis: Trends, Data, and Growth Projections 

BIS Research, a leading market research firm, has released multiple reports on the cell and gene therapy market, focusing on technologies, manufacturing, drug delivery, and quality control processes. These reports discuss the challenges, growth factors, future opportunities, and possible business strategies driving the growth in the market. 

Cell and Gene Therapy Market: The global cell and gene therapy market was valued at $2.59 billion in 2020, and it is expected to grow at a CAGR of 33.82% and reach a value of $25 billion in 2027. The detailed study is a compilation of 9 market data tables, and 170 figures spread across 285 pages.  

Covered in the report: Market overview, Industry analysis, Market dynamics, Cell and gene therapy manufacturing capacity by company, Competitive landscape, Global cell and gene therapy market by product, Global cell and gene therapy market by therapeutic classes, and Global cell and gene therapy market by region. 

Check Full Coverage of the Report - Access TOC   

Viral Vector and Plasmid Manufacturing Market: The global viral vector and plasmid manufacturing market, with a base year in 2018, had a market size of $1.15 billion. The forecast period spans from 2020 to 2030, with an estimated market value of $5.86 billion by 2030, reflecting a CAGR of 16.28%. The comprehensive market report comprises 14 data tables, 275 pages, and 157 figures, offering detailed insights and analysis. 

Covered in the report: Market overview, Industry analysis, Market dynamics, Competitive landscape, Global viral vector and plasmid manufacturing market by vector, Global viral vector and Plasmid manufacturing market by disease, Global viral vector and Plasmid manufacturing market by application, and Global viral vector and plasmid manufacturing market by region. 

Check Full Coverage of the Report - Access TOC   

Cell and Gene Therapy Drug Delivery Devices Market: The global cell and gene therapy drug delivery devices market was valued at $55.75 thousand in 2019, and is expected to reach $375.13 thousand by 2030, registering a CAGR of 16.61% during the forecast. The detailed report is a compilation of 19 market data tables, 288 pages, and 188 figures. 

Covered in the report: Market overview, Industry analysis, Market dynamics, Competitive landscape, Emerging technology landscape, Global cell and gene therapy drug delivery devices market by product type, Global cell and gene therapy drug delivery devices market by commercialized drugs, and Global cell and gene therapy drug delivery devices market by region. 

Check Full Coverage of the Report - Access TOC   

Cell and Gene Therapy Manufacturing QC Market: The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is anticipated to reach $10.65 billion by 2033, witnessing a CAGR of 16.85% during the forecast period 2023-2033. The detailed study is a compilation of 10 market data tables, and 315 figures spread across 361 pages. 

Covered in the report: Market overview, Industry analysis, Market dynamics, Competitive landscape, Emerging technology landscape, Global cell and gene therapy manufacturing QC market by therapy type, Global cell and gene therapy manufacturing QC market by offering, Global cell and gene therapy manufacturing QC market by process, Global cell and gene therapy manufacturing QC market by technology, Global cell and gene therapy manufacturing QC market by application, and Global cell and gene therapy manufacturing QC market by region. 

Check Full Coverage of the Report - Access TOC   

Key Players in the Cell and Gene Therapy Industry 

• Amgen Inc 
• bluebird bio, Inc 
• Castle Creek Pharmaceutical Holdings 
• Kite Pharma, Inc 
• Novartis AG 
• Orchard Therapeutics plc 
• Pfizer, Inc 
• Spark Therapeutics, Inc 
• Vericel Corporation 
• Dendreon Pharmaceuticals LLC 
• Human Stem Cells Institute 
• Kolon TissueGene, Inc 
• Organogenesis Holdings Inc 
• Pfizer, Inc. 
• Renova Therapeutics 
• Shanghai Sunway Biotech Co. Ltd 
• Sibiono GeneTech Co. Ltd 
• Bausch & Lomb Incorporated 
• Becton, Dickinson and Company 
• Helixmith Co., Ltd (ViroMed Co., Ltd) 
• uniQure N.V. 
• Bio-Techne Corporation 
• bioMérieux SA 
• Danaher. (Cytiva) 
• F. Hoffmann-La Roche Ltd 
• Lonza. 
• Miltenyi Biotec B.V. & Co. KG 
• Sartorius AG 
• Thermo Fisher Scientific Inc. 
• WuXi AppTec 
• AGC Biologics. 
• Charles River Laboratories International, Inc. 
• Catalent, Inc 
• Eurofins Scientific 
• Merck KGaA 
• FUJIFILM Holdings Corporation 
• GENERAL ELECTRIC 
• MolMed S.p.A. 
• Novasep Holding 
• Oxford Biomedica plc 
• GenScript 
• Boehringer Ingelheim 
• Takara Bio Inc. 
• Aldevron, L.L.C. 

Evaluate Free Sample Report- Cell and Gene Therapy Market Sample 

Market Analysis: Drivers, Challenges and Opportunities 

Market Drivers 

The cell and gene therapy industry is experiencing robust growth driven by various factors. The increasing prevalence of cancer and chronic diseases has heightened the demand for innovative therapies, positioning the sector as a key player in addressing unmet medical needs. A rising number of clinical trials underscore the commitment to advancing treatment options and exploring advanced therapeutic modalities. Substantial funding and investments further fuel research and development initiatives, fostering innovation and progress in the field. The industry benefits from a favorable regulatory environment, with FDA approvals lending credibility and facilitating market access for cell and gene therapy products. 

Specific market drivers highlight vital trends shaping the industry's trajectory. The rapid adoption of viral vectors and plasmids for therapy development reflects the industry's adaptability to advanced technologies. Increasing clinical studies on gene therapy demonstrate a commitment to exploring novel treatment modalities. A favorable funding scenario for vector-based therapies also stimulates industry growth. On the demand side, the growing production of cell and gene therapies necessitates increased quality control testing, driven by rising approvals and investment in therapy development. 

Download Free Sample: Cell and Gene Therapy Drug Delivery Devices Market Sample 

Market Challenges 

The cell and gene therapy industry confronts significant challenges, including stringent government regulations, needle-related injuries, and high manufacturing and quality control costs limiting widespread adoption. The unaffordable cost of gene therapies and complexities in large-scale vector production pose economic obstacles, hindering patient access. The lack of a reliable vector production system, intricate manufacturing setups, and a laborious therapeutic commercialization process further impedes industry growth. 

Download Free Sample: Global Viral Vector and Plasmid Manufacturing Market Sample 

Market Opportunities 

The cell and gene therapy industry presents promising opportunities amidst its challenges. A robust pipeline and drug approvals indicate fertile ground for innovation and therapeutic advancements. The continuous entry of new market participants creates an opportunity for expanding manufacturing facilities and quality control (QC) testing services, fostering industry growth. The introduction of technologically advanced products in QC testing for cell and gene therapies reflects the evolving landscape, providing avenues for enhanced efficiency and precision. 

Rising demand for synthetic genes and the emergence of next-generation vectors signify growing opportunities in genetic therapies. Moreover, the increasing number of mergers and acquisitions within the cell and gene industry presents strategic prospects for collaboration and synergy. The industry's dynamic nature, technological advancements, and strategic partnerships open doors for continued innovation and expansion. 

Download Free Sample: Cell and Gene Therapy Manufacturing QC Market Sample 

Other Related Reports 

CRISPR Gene Editing Market 

Global Viral and Non-Viral Vector Manufacturing Market 

Next-Generation Biomanufacturing Market 

Cell and Gene Therapy Biomanufacturing Market 

Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV 

Analyst Note 

BIS principal analyst: "Key industry trends include a heightened emphasis on automation, leveraging artificial intelligence and robotics for efficient, scalable, and cost-effective production. Companies are expanding production capacities by constructing and extending new facilities to meet increasing treatment demand. The adoption of closed and variable manufacturing systems is increasing, aiming to minimize contamination risks and enhance production efficiency." 

Contact Now- Consult for Custom Research    

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing   

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch